SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017959
Filing Date
2022-06-28
Accepted
2022-06-28 16:05:47
Documents
14
Period of Report
2022-06-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42078
2 form8-k_001.jpg GRAPHIC 5613
3 ex3-4.htm EX-3.4 12027
  Complete submission text file 0001493152-22-017959.txt   246238

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lpcn-20220628.xsd EX-101.SCH 2959
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lpcn-20220628_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lpcn-20220628_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3718
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 221050113
SIC: 2834 Pharmaceutical Preparations